Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > 792,000 shares traded today

<< Previous

Bullboard Posts

Next >>

Comment by EbbFlow88on Jul 13, 2021 4:32pm

150 Views

Post# 33537183

RE:RE:RE:RE:792,000 shares traded today

Thanks for the info mugsy.

Now we have our platform and it's time to grow. Skimming through the annual reports for PLB, you can clearly see stepwise growth over its lifetime. I think this team can do it again.

Once they streamline costs and get new products to market it will be great to see consistent cash flow from operations and not rely on their investments for cash generation.

Then the snowball can continue to grow.

<< Previous

Bullboard Posts

Next >>

Canadian government to fund Electric Royalties portfolio property